Andon Health

Andon Health (九安医疗) is a Chinese company that develops and sells medical devices and diagnostic reagent testing products. According to Chinese Wikipedia, it was formerly known for electronic medical equipment such as electronic blood pressure monitors and blood glucose meters. The company is described in public sources as a medical device and reagent testing products company based in the People's Republic of China. Its official website is andon.com.cn. The available evidence does not specify its founding year, headquarters city, ownership structure, or listing status, so those details are not asserted here.

Andon Health (九安医疗) is a Chinese medical device and diagnostic reagent testing company. Chinese Wikipedia states that it was formerly mainly engaged in electronic medical equipment such as electronic blood pressure monitors and blood glucose meters. The evidence available does not provide dated events, founding details, or a chronological account of the company's development, so no specific years or turning points are asserted here. The company is identified as being based in the People's Republic of China and operates an official website at andon.com.cn.

• Electronic blood pressure monitors

  Electronic medical equipment that Chinese Wikipedia identifies as a former main product line of Andon Health.

• Blood glucose meters

  Electronic medical equipment that Chinese Wikipedia identifies as a former main product line of Andon Health.

• Medical devices and diagnostic reagent testing products

  The company is described in public sources as a medical device and reagent testing products company.

• 2021

  “Demon stock” selectively discloses COVID test progress, receives regulatory letter; executives summoned

  Andon Health’s share price soared amid the COVID antigen testing hotspot; in December 2021 it disclosed FDA authorization progress early on Hudongyi and was questioned as “escorting” equity incentive exercises; in January 2022 it disclosed only partial Omicron test results, and a Shenzhen Stock Exchange regulatory letter said its Hudongyi replies had repeatedly been inaccurate and incomplete. Shenzhen Stock Exchange regulatory letter; Tianjin Securities Regulatory Bureau held regulatory talks with chairman Liu Yi and board secretary Wu Tong.

  Source

Read more

1. 1九安医疗 - Wikidatawikidata.org
2. 2九安医疗 - 维基百科zh.wikipedia.org
3. 3“Demon stock” selectively discloses COVID test progress, receives regulatory letter; executives summonedcsrc.gov.cn
4. 4“Demon stock” selectively discloses COVID test progress, receives regulatory letter; executives summoned21jingji.com
5. 5“Demon stock” selectively discloses COVID test progress, receives regulatory letter; executives summonedjiemian.com